NCT06820476View on ClinicalTrials.gov

A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

February 9, 2025

Primary Completion Date

May 14, 2025

Study Completion Date

May 14, 2025

Conditions
OverweightObesity
Interventions
DRUG

NNC0487-0111

Participants will be randomized to receive NNC0487-0111 tablet orally at dose levels 1, 2, or 3.

DRUG

Placebo (NNC0487-0111)

Participants will be randomized to receive a placebo tablet orally matched to NNC0487-0111.

Trial Locations (2)

250000

Jinan Central Hospital Affiliated to Shandong University, Ji'Nan

Jinan Central Hospital, Ji'Nan

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY